409 related articles for article (PubMed ID: 38558317)
1. Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review.
Talaee N; Azadvar S; Khodadadi S; Abbasi N; Asli-Pashaki ZN; Mirabzadeh Y; Kholghi G; Akhondzadeh S; Vaseghi S
Eur J Clin Pharmacol; 2024 Jul; 80(7):983-1016. PubMed ID: 38558317
[TBL] [Abstract][Full Text] [Related]
2. Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Kanekar S; Sheth CS; Ombach HJ; Olson PR; Bogdanova OV; Petersen M; Renshaw CE; Sung YH; D'Anci KE; Renshaw PF
Pharmacol Biochem Behav; 2018 Jul; 170():25-35. PubMed ID: 29738811
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.
Amada N; Hirose T; Suzuki M; Kakumoto Y; Futamura T; Maeda K; Kikuchi T
Neuropsychopharmacol Rep; 2023 Mar; 43(1):132-136. PubMed ID: 36649966
[TBL] [Abstract][Full Text] [Related]
4. Serum BDNF levels before treatment predict SSRI response in depression.
Wolkowitz OM; Wolf J; Shelly W; Rosser R; Burke HM; Lerner GK; Reus VI; Nelson JC; Epel ES; Mellon SH
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1623-30. PubMed ID: 21749907
[TBL] [Abstract][Full Text] [Related]
5. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Sanchez C; Reines EH; Montgomery SA
Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
[TBL] [Abstract][Full Text] [Related]
6. Which SSRIs most effectively treat depression in adolescents?
DeLucia V; Kelsberg G; Safranek S
J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691
[TBL] [Abstract][Full Text] [Related]
7. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.
Kaplan C; Zhang Y
J Ment Health Policy Econ; 2012 Dec; 15(4):171-8. PubMed ID: 23525835
[TBL] [Abstract][Full Text] [Related]
8. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
9. Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
Shih YC; Bekele NB; Xu Y
Pharmacoeconomics; 2007; 25(10):843-62. PubMed ID: 17887806
[TBL] [Abstract][Full Text] [Related]
10. Sertraline versus other antidepressive agents for depression.
Cipriani A; La Ferla T; Furukawa TA; Signoretti A; Nakagawa A; Churchill R; McGuire H; Barbui C
Cochrane Database Syst Rev; 2009 Apr; (2):CD006117. PubMed ID: 19370626
[TBL] [Abstract][Full Text] [Related]
11. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
12. The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
J Pharm Pharmacol; 2001 Apr; 53(4):449-61. PubMed ID: 11341361
[TBL] [Abstract][Full Text] [Related]
13. Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients.
Dvojkovic A; Nikolac Perkovic M; Sagud M; Nedic Erjavec G; Mihaljevic Peles A; Svob Strac D; Vuksan Cusa B; Tudor L; Kusevic Z; Konjevod M; Zivkovic M; Jevtovic S; Pivac N
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110016. PubMed ID: 32534176
[TBL] [Abstract][Full Text] [Related]
14. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Zhou C; Zhong J; Zou B; Fang L; Chen J; Deng X; Zhang L; Zhao X; Qu Z; Lei Y; Lei T
PLoS One; 2017; 12(2):e0172270. PubMed ID: 28241064
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
Sánchez C; Hyttel J
Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
[TBL] [Abstract][Full Text] [Related]
16. SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.
Dell'Agnello G; Ceravolo R; Nuti A; Bellini G; Piccinni A; D'Avino C; Dell'Osso L; Bonuccelli U
Clin Neuropharmacol; 2001; 24(4):221-7. PubMed ID: 11479393
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.
Chawla N; Anothaisintawee T; Charoenrungrueangchai K; Thaipisuttikul P; McKay GJ; Attia J; Thakkinstian A
BMJ; 2022 Jan; 376():e066084. PubMed ID: 35045991
[TBL] [Abstract][Full Text] [Related]
18. The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
Exp Toxicol Pathol; 1999 Jul; 51(4-5):309-14. PubMed ID: 10445388
[TBL] [Abstract][Full Text] [Related]
19. Review of sertraline and its clinical applications in psychiatric disorders.
McRae AL; Brady KT
Expert Opin Pharmacother; 2001 May; 2(5):883-92. PubMed ID: 11336629
[TBL] [Abstract][Full Text] [Related]
20. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV.
Caballero J; Nahata MC
Ann Pharmacother; 2005 Jan; 39(1):141-5. PubMed ID: 15562140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
